First-Of-Its-Kind Prostate Cancer Imaging Agent Approved By FDA
Executive Summary
Gallium has been approved as a diagnostic agent by the US agency to help early detection of prostate cancer spread in patients who qualify for treatment with surgery or radiation therapy.
You may also be interested in...
FDA To Hold Postponed 3-Day Pediatric Device Workshop In February
The US agency plans to hold a virtual workshop that will use breakout sessions to get stakeholder feedback on specific hurdles preventing more pediatric devices coming to market.
FDA Sets New Restrictions For Authorized N95 Decontamination Systems
After reviewing real-world data, the US agency says the decontamination systems should only be used for compatible facemasks and should not be used to clean a mask more than four times.
AdvaMed: Medtech Industry Wants Seat At Biden’s Coronavirus Response Table
The largest medical device lobby group in the US says it’s open to the administration’s decision to invoke the Defense Production Act to boost testing and PPE production, but wants to be consulted on how to implement it.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: